0
Clinical Investigations: ASTHMA |

Effect of Salmeterol on Seasonal Changes in Airway Responsiveness and Exhaled Nitric Oxide in Pollen-Sensitive Asthmatic Subjects*

Luis Prieto, PhD; Valentina Gutiérrez, PhD; Vicente Torres, MD; Sonia Uixera, MD; Julio Marín, PhD
Author and Funding Information

*From the Sección de Alergología (Drs. Prieto, Gutiérrez, and Uixera), The NAOMI Project, and Servicio de Anatomía Patológica (Dr. Torres), Hospital Universitario Dr. Peset, Valencia, Spain; and Universidad de Valencia (Dr. Marín), Valencia, Spain.

Correspondence to: Luis Prieto, PhD, Sección de Alergología, Hospital Universitario Dr. Peset, C/Gaspar Aguilar 90, 46017 Valencia, Spain; e-mail: prieto_jes@gva.es



Chest. 2002;122(3):798-805. doi:10.1378/chest.122.3.798
Text Size: A A A
Published online

Objective: Using a model of natural allergen exposure, we examined the effect of regular treatment with salmeterol on allergen-induced changes in airway responsiveness and exhaled nitric oxide (ENO).

Design: Double-blind, randomized, parallel-group study.

Setting: Specialist allergy unit in a university hospital.

Patients: Asthmatic patients sensitized to pollen allergens were randomly allocated to monotherapy with salmeterol (n = 14) or placebo (n = 13).

Interventions: Salmeterol, 25 μg, and placebo inhalers, two puffs bid, for 6 weeks.

Measurements: Spirometry, the level of a provocative concentration of a substance (methacholine) causing a 20% fall in FEV1 (PC20), the PC20 level for adenosine 5′-monophosphate (AMP), and ENO were measured before the pollen season and were repeated at the height of the pollen season after 6 weeks of treatment with salmeterol or placebo.

Results: The decrease in FEV1 during the pollen season was significantly larger in the placebo group than in the salmeterol group, the mean difference in the change between the groups being 0.20 L (95% confidence interval, 0.03 to 0.35; p = 0.047). Changes in PC20 for methacholine, PC20 for AMP, and ENO levels were not significantly different between treatment groups. However, a mean (± SEM) decrease in the PC20 for methacholine of −1.0 ± 0.4 doubling concentrations was observed within the placebo group (p = 0.03), whereas no significant changes were observed within the salmeterol group. A significant decrease in PC20 for AMP (doubling concentrations) was observed within the placebo group (−2.1 ± 0.6; p = 0.003) and the salmeterol group (−1.5 ± 0.4; p = 0.003). ENO concentrations increased significantly among the placebo and the salmeterol groups during natural pollen exposure.

Conclusion: These observations indicate that natural allergen exposure and the regular use of salmeterol are not associated with a greater increase in ENO and airway responsiveness than allergen exposure alone.

Figures in this Article

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Find Similar Articles
CHEST Journal Articles
PubMed Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543